- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14:34 | HeartSciences Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 14:06 | Fortitude Mining to merge with HeartSciences in all-stock deal | 2 | Investing.com | ||
| 13:30 | Fortitude Mining Holdings, Inc. and HeartSciences Inc. Announce Business Combination, Aiming to Bring a Leading Vertically-Integrated Zcash Mining Platform to the Public Markets | 5 | Business Wire | FAIRPORT, N.Y.--(BUSINESS WIRE)--Fortitude Mining Holdings, Inc. ("Fortitude"), a vertically-integrated digital asset mining platform anchored in Zcash, and HeartSciences Inc. (Nasdaq: HSCS) ("HeartSciences")... ► Artikel lesen | |
| 11.06. | HeartSciences Inc.: European Patent Granted for ECG-Based Assessment of Diastolic Function, Expands HeartSciences' Patent Portfolio to More Than 45 Granted Patents | 199 | GlobeNewswire (Europe) | Southlake, TX, June 11, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on advancing... ► Artikel lesen | |
| 02.06. | HeartSciences Inc.: HeartSciences Launches MyoVista Insights Version 1.3 with AI-ECG Algorithm Marketplace and First FDA-Cleared Algorithm | 1 | GlobeNewswire (USA) | ||
| 19.05. | HeartSciences signs North Shore Health for MyoVista platform | 1 | Investing.com | ||
| HEARTSCIENCES Aktie jetzt für 0€ handeln | |||||
| 19.05. | HeartSciences Inc.: HeartSciences Signs Commercial Agreement with North Shore Health, the First Hospital Deployment from the Cibolo Health Network | 1 | GlobeNewswire (USA) | ||
| 06.05. | HeartSciences Inc. - 8-K, Current Report | - | SEC Filings | ||
| 05.05. | HeartSciences Inc.: HeartSciences Signs First SaaS Revenues Agreement following full launch of MyoVista Insights | 184 | GlobeNewswire (Europe) | Southlake, TX, May 05, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on advancing... ► Artikel lesen | |
| 14.04. | HeartSciences Inc.: HeartSciences Reminds Its Shareholders to Submit Their Vote at the Upcoming April 30, 2026, Annual Shareholders Meeting | 1 | GlobeNewswire (USA) | ||
| 03.04. | HeartSciences Inc. - 8-K, Current Report | - | SEC Filings | ||
| 25.03. | HeartSciences Inc.: HeartSciences' MyoVista Insights Receives Epic Toolbox Designation for ECG Management System Category | 1 | GlobeNewswire (USA) | ||
| 17.03. | Heart Test Laboratories GAAP EPS of -$0.63 beats by $0.19 | 1 | Seeking Alpha | ||
| 16.03. | HeartSciences Inc.: HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update | 249 | GlobeNewswire (Europe) | Southlake, Texas, March 16, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on advancing... ► Artikel lesen | |
| 16.03. | HeartSciences Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 16.03. | HeartSciences Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 05.02. | HeartSciences Inc.: University of West England Adopts HeartSciences' MyoVista Insights Platform and MyoVista wavECG Device to Establish ECG Education and Technology Reference Center | 1 | GlobeNewswire (USA) | ||
| 29.01. | HeartSciences Inc.: Cibolo Health Designates HeartSciences' MyoVista Insights as Endorsed ECG Management Platform for Network of 123 Independent Hospitals | 1 | GlobeNewswire (USA) | ||
| 16.01. | HeartSciences Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 15.12.25 | HeartSciences Inc.: HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update | 1.452 | GlobeNewswire (Europe) | Southlake, TX, Dec. 15, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on advancing electrocardiography... ► Artikel lesen |
1 2 Weiter >>
23 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HEALWELL AI | 0,490 | -0,31 % | HEALWELL AI informiert über Neuigkeiten aus dem Unternehmen: Annahme der Forschungsergebnisse aus provinzübergreifendem KI-Pilotprojekt beim AMIA-Symposium und Stärkung der Bilanz durch SpaceX-Beteiligung | - HEALWELL hat erfolgreich ein Pilotprojekt zur Bewertung seiner auf DARWEN basierenden KI-Lösungen SMART Summary und SMART Search in mehreren kanadischen Provinzen
abgeschlossen. Das... ► Artikel lesen | |
| INSULET | 120,90 | -0,53 % | DexCom, Insulet gain news Buys at Deutsche Bank despite recent selloff | ||
| LIFEWARD | 6,970 | -1,34 % | Lifeward Ltd.: Lifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilitation Portfolio and Advance Biomed Platform | Veteran physician- medical affairs and clinical research leader brings 30 years of rehabilitation medicine experience and deep expertise in neuroscience- mobility technologies, and metabolic disease... ► Artikel lesen | |
| IMUNON | 1,620 | 0,00 % | Imunon, Inc.: IMUNON Announces Data Monitoring Committee Recommends Continuation of Phase 3 OVATION 3 Study Without Modification | On track for enrollment of 80 participants by Q1 2027 Trial is supported by Phase 2 results showing significant improvement in overall survival in women with newly diagnosed advanced ovarian cancer... ► Artikel lesen | |
| LANTHEUS | 93,60 | +0,65 % | XETR NEW INSTRUMENTS AVAILABLE ON XETRA - 04.06.2026 | Folgende Wertpapiere werden in den Handel an folgenden Handelsplätzen (MIC Code) im Quotation Board an der Frankfurter Wertpapierbörse (FWB) aufgenommen. Die Notierung an anderen Handelsplätzen im Quotation... ► Artikel lesen | |
| INSPIRE MEDICAL SYSTEMS | 36,200 | 0,00 % | Evercore ISI stuft Inspire Medical Aktie wegen Kodierungsproblemen herab | ||
| INSPIREMD | 0,635 | +0,79 % | InspireMD Posts Positive CGUARDIANS II Data for CGuard Prime TCAR | ||
| GT BIOPHARMA | 0,490 | -0,08 % | GT Biopharma, Inc.: GT Biopharma Announces First Patient Dosed in Phase 1 Trial of GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager for Solid Tumors | GTB-5550 is now the 3rd TriKE- to enter the clinic and an expansion into a broader solid tumor opportunity, with the Phase 1 trial likely to focus on prostate cancer patients during the dose escalation... ► Artikel lesen | |
| INOGEN | 5,550 | 0,00 % | Inogen Inc - S-8, Securities to be offered to employees in employee benefit plans | ||
| MYOMO | 1,118 | +0,90 % | Myomo übertrifft Q1-Prognosen, Aktie gibt dennoch nach | ||
| INTELLIGENT BIO SOLUTIONS | 2,290 | -3,78 % | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry | Interference Study designed to validate system specificity in the presence of potentially interfering substances commonly encountered in real-world settings Company expects to complete the study by... ► Artikel lesen | |
| INCANNEX HEALTHCARE | 3,320 | +2,15 % | Incannex Healthcare: Incannex Receives A$6.0 Million R&D Tax Incentive Refund for FY25, Further Strengthening Balance Sheet and Financial Flexibility | NEW YORK and MELBOURNE, Australia, June 10, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) ("Incannex" or the "Company"), a clinical-stage biopharmaceutical company advancing innovative... ► Artikel lesen | |
| HEARTFLOW | 34,000 | +0,47 % | Heartflow, Inc. - 8-K, Current Report | ||
| GLUCOTRACK | 0,360 | -1,07 % | GlucoTrack, Inc.: Glucotrack Reports First Quarter 2026 Financial Results and Recent Corporate Highlights | Submitted Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration (FDA) to initiate a U.S. clinical study for fully implantable continuous blood glucose monitoring... ► Artikel lesen | |
| LEXARIA BIOSCIENCE | 0,570 | -2,16 % | Lexaria Bioscience Corp.: Lexaria's Animal Study GLP-1-A26-1 Has Begun Dosing on Schedule | Potentially Valuable Novel Compositions Being InvestigatedLexaria Also Receives Additional New Granted Patent KELOWNA, BC / ACCESS Newswire / June 23, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX)... ► Artikel lesen |
Das Unternehmen HEARTSCIENCES INC kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von +1,015 (+57,34 %) liegt der Kurs bei 2,785 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu HEARTSCIENCES INC finden Sie auf Wallstreet Online.